Authorization

Khiron CEO Alvaro Torres to Present at AltaCorp/ATB 8th Annual Institutional Investor Conference

TORONTO, Jan. 6, 2020 /CNW/ -A Khiron Life Sciences Corp. ("Khiron"A or the "Company") (TSXV:A KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that CEO and Director Alvaro Torres will speak on the International Expansion panel at the AltaCorp/ATB 8th Annual Institutional Investor Conference at 3:10pm on January 14, 2020. Mr. Torres and other members of the Khiron leadership team will also be conducting one-on-one meetings at the conference, taking place January 14-16, 2020 at the Shangri-La Hotel Toronto.
Khiron CEO Alvaro Torres to Present at AltaCorp/ATB 8th Annual Institutional Investor Conference
In addition to Khiron, the AltaCorp/ATB Conference Life Sciences Day on January 14 will also feature select companies across the cannabis sector value chain, including cannabinoid-derived pharmaceuticals, biosynthetics, extraction, as well as leading brands in the recreational, medical and retail markets.About Khiron Life Sciences Corp.
Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The company delivers best in class regulatory compliance, has the first approved set of CBD cosmetic products on shelf inA Colombia, and is currently facilitating testing to meet and surpass all license requirements for commercial cannabis derived products.With a focused regionalA strategy and patient oriented approach, the Company combines global scientific expertise, agricultural advantages, branded product market entrance experienceA and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain,A epilepsy, depression and anxiety in the Latin American market of over 620 million people. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with anA experienced executive team, and a knowledgeable Board of Directors thatA includes former President of Mexico, Vicente Fox.A 
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2020    »
ПнВтСрЧтПтСбВс
 12
3456789
10111213141516
17181920212223
24252627282930
31